MedPath

An explorative and experimental study to assess the feasibility, acceptability, and effectiveness of early intervention with light, lifestyle and ImCT therapy in individuals at risk for severe mental illness

Conditions
mood swings
prodromal symptoms of SMI
10037176
Registration Number
NL-OMON53231
Lead Sponsor
GGZ Eindhoven (Eindhoven)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Must be bound to start the early intervention program being evaluated Aged
16-35, or > 35 by indication of the patients* treating clinician Sufficient
knowledge of Dutch or English language Ability to give informed consent Willing
to complete daily monitoring throughout the duration of the study

Exclusion Criteria

Any current or previous neurological disorder or organic brain disease. IQ <
70 estimated by clinician. Current severe substance or alcohol misuse impacting
treatment (clinicians assessment).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Changes in the level of mood and anxiety symptoms, as well as circadian rhythm<br /><br>and activity levels measured at multiple time points, will give insight into<br /><br>potential effectivity and support the importance of future randomized<br /><br>controlled trials (RCT). Also, experience sample monitoring (ESM), adverse<br /><br>(side) effects, drop-out rates and qualitative review of therapy will provide<br /><br>feasibility and acceptability outcomes.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>n.a.</p><br>
© Copyright 2025. All Rights Reserved by MedPath